Cannabotech Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CNTC.TA research report →
Price Chart
About the company
Cannabotech Ltd. focuses on pioneering medical and wellness solutions derived from cannabinoids. The company offers pharmaceutical treatments for various health conditions, bespoke cannabinoid formulations, and a selection of CBD-infused skincare and dietary supplements.
- CEO
- Elchanan Shaked
- IPO
- 2021
- Employees
- 6
- HQ
- Rishon LeZion, IL
Get TickerSpark's AI analysis on CNTC.TA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $1.62M
- P/E
- -0.40
- PEG
- 0.00
- P/S
- 0.00
- P/B
- 1.92
- EV/EBITDA
- -1.29
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 4053.58%
- ROIC
- -472.76%
Latest fiscal year · YoY change
- Revenue
- $-111,000-109.1%
- Gross Profit
- $-3,217,000-155.9%
- Op Income
- $-8,969,000
- Net Income
- $-8,455,000+47.6%
- EPS
- $-29.07+62.2%
- OCF Growth
- +35.0%
- FCF Growth
- +35.1%
- 52W High
- $1880.00
- 52W Low
- $80.00
- 50D MA
- $168.70
- 200D MA
- $315.10
- Beta
- 0.53
- RSI (14)
- 15
- Avg Volume
- 69.69K
No earnings-call transcripts are available for CNTC.TA yet.
- Free Float
- 0.0%
- Shares Outstanding
- 1.97M
- Float Shares
- 0
Our CNTC.TA coverage
Recent articles, reports, and earnings notes.
No research on CNTC.TA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CNTC.TA report →